PRICE T ROWE ASSOCIATES INC /MD/ - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,581
+7.4%
22,608
+10.4%
0.00%
Q2 2023$1,472
+46.8%
20,476
+26.0%
0.00%
Q1 2023$1,003
-10.2%
16,249
+12.2%
0.00%
Q4 2022$1,117
-99.8%
14,479
+2.7%
0.00%
Q3 2022$630,000
+12.5%
14,099
-3.6%
0.00%
Q2 2022$560,000
-5.9%
14,627
+1.7%
0.00%
Q1 2022$595,000
+52.6%
14,382
+39.4%
0.00%
Q4 2021$390,000
-41.2%
10,314
-48.7%
0.00%
Q3 2021$663,000
-98.7%
20,110
-97.3%
0.00%
-100.0%
Q2 2021$50,477,000
+42.1%
748,247
+19.3%
0.01%
+25.0%
Q1 2021$35,520,000
-58.0%
627,338
-39.6%
0.00%
-55.6%
Q4 2020$84,668,000
+13.3%
1,039,255
-0.9%
0.01%0.0%
Q3 2020$74,740,000
-16.3%
1,048,985
-3.3%
0.01%
-18.2%
Q2 2020$89,263,000
+103.6%
1,084,871
+45.5%
0.01%
+57.1%
Q1 2020$43,850,000
-73.6%
745,360
-53.6%
0.01%
-68.2%
Q4 2019$166,099,000
+1057.6%
1,606,991
+126.7%
0.02%
+1000.0%
Q3 2019$14,348,000
-3.7%
708,871
+22.5%
0.00%0.0%
Q2 2019$14,906,000578,8590.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders